KBC Group’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,555
Closed -$43K – 1877
2026
Q2
$43K Hold
2,555
– – ﹤0.01% 1755
2026
Q1
$30K Hold
2,555
– – ﹤0.01% 1797
2025
Q4
$39K Hold
2,555
– – ﹤0.01% 1693
2025
Q3
$55K Hold
2,555
– – ﹤0.01% 1613
2025
Q2
$57K Sell
2,555
-1,407
-36% -$31.3K ﹤0.01% 1549
2025
Q1
$94K Hold
3,962
– – ﹤0.01% 1514
2024
Q4
$84K Buy
3,962
+1,577
+66% +$41.4K ﹤0.01% 1661
2024
Q3
$77K Buy
2,385
+576
+32% +$17K ﹤0.01% 1462
2024
Q2
$43K Buy
1,809
+216
+14% +$5.54K ﹤0.01% 1706
2024
Q1
$48K Hold
1,593
– – ﹤0.01% 1584
2023
Q4
$51K Hold
1,593
– – ﹤0.01% 1513
2023
Q3
$47K Buy
+1,593
New +$57.3K ﹤0.01% 1499

Other funds holding SGRY

KBC Group's SGRY Position: Q3 2026 in Review

KBC Group sold out of Surgery Partners (SGRY) in Q3 2026, closing a stake of 2,555 shares — an estimated $43K sold.

KBC Group first reported a position in SGRY in Q3 2023 and held it in 12 quarters. The position peaked at $94K in Q1 2025. 42 funds tracked by Wall St. Rank hold SGRY as of Q3 2026.

  • KBC Group reported no remaining Surgery Partners position as of Q3 2026 after selling out during the quarter.
  • KBC Group sold 2,555 Surgery Partners shares in Q3 2026, an estimated $43K.
  • KBC Group first reported a position in Surgery Partners in Q3 2023 and held it in 12 quarters.
  • KBC Group's Surgery Partners position peaked at $94K in Q1 2025.
  • 42 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.